Brian Biesman, MD
Ophthalmology · Nashville, TNNPI 1700848934
Payments from drug & device makers
Across 459 payments — averaging $7069.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2.1M
- Merz North America, Inc.$790K
- Solta Medical, A Division Of Bausch Health US, LLC$191K
- Endo Pharmaceuticals Inc.$75K
- Galderma Laboratories, L.p.$29K
- Lumenis BE LTD$15K
- plus $12K from 7 others
Across 44 payments — averaging $12,855 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$266K
- Bausch Health US, LLC$209K
- Merz North America, Inc.$58K
- Galderma Laboratories, L.p.$32K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 254 | $2,133,755 |
| Merz North America, Inc. | 92 | $789,702 |
| Solta Medical, A Division Of Bausch Health US, LLC | 23 | $190,748 |
| Endo Pharmaceuticals Inc. | 22 | $75,499 |
| Galderma Laboratories, L.p. | 45 | $28,624 |
| Lumenis BE LTD | 1 | $15,000 |
| Revance Therapeutics, Inc. | 16 | $6,782 |
| Pfizer | 1 | $3,750 |
| Botanix SB Inc | 1 | $1,000 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $22 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Dermira, Inc. | 1 | $12 |
How this compares
$3,244,951 in reported general payments places this provider in the 95th percentile of 323 ophthalmology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Nashville
- Deborah ShermanNashville$3.1M
- Gary JerkinsNashville$2.9M
- Jeffrey HornNashville$1.2M
- Jeffrey KammerNashville$919K
- Stephen KimNashville$242K
- Shriji PatelNashville$214K
- Edward ChaumNashville$203K
- Louise MawnNashville$96K
- Avni FinnNashville$66K
- Meghan FlemmonsNashville$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.